Tal Patalon

3.7k total citations · 1 hit paper
50 papers, 1.6k citations indexed

About

Tal Patalon is a scholar working on Infectious Diseases, Health and Modeling and Simulation. According to data from OpenAlex, Tal Patalon has authored 50 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Infectious Diseases, 13 papers in Health and 10 papers in Modeling and Simulation. Recurrent topics in Tal Patalon's work include SARS-CoV-2 and COVID-19 Research (26 papers), COVID-19 Clinical Research Studies (19 papers) and Vaccine Coverage and Hesitancy (13 papers). Tal Patalon is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (26 papers), COVID-19 Clinical Research Studies (19 papers) and Vaccine Coverage and Hesitancy (13 papers). Tal Patalon collaborates with scholars based in Israel and United States. Tal Patalon's co-authors include Sivan Gazit, Gabriel Chodick, Amir Ben‐Tov, Asaf Peretz, Galit Perez, Esma Herzel, Jacob Kuint, Idan Yelin, Roy Kishony and Rachel Katz and has published in prestigious journals such as Science, Nature Medicine and Nature Communications.

In The Last Decade

Tal Patalon

45 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Initial report of decreased SARS-CoV-2 viral load after inoculation with the BNT162b2 vaccine

2021 305 citations Matan Levine-Tiefenbrun, Idan Yelin et al. Nature Medicine profile →

Peers

Countries citing papers authored by Tal Patalon

Since Specialization

Citations

This map shows the geographic impact of Tal Patalon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tal Patalon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tal Patalon more than expected).

Fields of papers citing papers by Tal Patalon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tal Patalon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tal Patalon. The network helps show where Tal Patalon may publish in the future.

Co-authorship network of co-authors of Tal Patalon

This figure shows the co-authorship network connecting the top 25 collaborators of Tal Patalon. A scholar is included among the top collaborators of Tal Patalon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tal Patalon. Tal Patalon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Incidence of Ocular Manifestation After Adult-Onset Inflammatory Bowel Disease: A 20-Year Population-Based Cohort Study 2025 ·Inflammatory Bowel Diseases ·Henit Yanai, (unknown), Amir Ben‐Tov, (unknown), Tal Patalon, Sivan Gazit, Amit Assa, Shiri Shulman	0
2	The association between familial Mediterranean fever and incident cirrhosis: A population-based matched cohort study 2025 ·Joint Bone Spine ·Michal Carmiel-Haggai, (unknown), (unknown), (unknown), (unknown), Mahmud Omar, ‬‬‬‬Abdulla Watad, Tal Patalon, Mohammad E. Naffaa	0
3	Strength in Numbers: Identifying a Significant Association between High Serum Ferritin Levels and Newly Diagnosed Malignancy in a Large Health Organization Cohort 2024 ·Cancer Epidemiology Biomarkers & Prevention ·(unknown), (unknown), (unknown), Tal Patalon, Sivan Gazit, Moshe Hoshen, Amir Dagan	1
4	A machine learning tool for early identification of celiac disease autoimmunity 2024 ·Scientific Reports ·Michael Dreyfuss, (unknown), Benjamin Lebwohl, (unknown), (unknown), (unknown), (unknown), (unknown), Sivan Gazit, Tal Patalon, Gabriel Chodick, Yehuda Shoenfeld, Amir Ben‐Tov	1
5	The Prevalence and Characteristics of Inflammatory Bowel Disease-related Ocular Involvement in Children 2024 ·Inflammatory Bowel Diseases ·Amir Ben‐Tov, (unknown), Tal Patalon, Sivan Gazit, Henit Yanai, Shiri Shulman, Amit Assa	2
6	Revealing misattributed parentage through the integration of genetic information into the electronic health record 2024 ·Bioethics ·(unknown), Sivan Gazit, (unknown), Tal Patalon	2
7	The course of patients with hairy cell leukemia during the omicron surge of the Covid‐19 pandemic 2023 ·Hematological Oncology ·Tamar Tadmor, (unknown), Tal Patalon, (unknown), Lior Rokach	0
8	An Outbreak of Parvovirus B19 in Israel 2023 ·Viruses ·Tal Patalon, Yaki Saciuk, (unknown), (unknown), Amir Ben‐Tov, Yaakov Segal, Sivan Gazit	19
9	Whole exome germline sequencing in early‐onset prostate cancer patients: Genomic findings and clinical outcomes 2023 ·The Prostate ·Nava Siegelmann‐Danieli, Victoria Neiman, Avital Bareket‐Samish, (unknown), Asaf Peretz, Hillel Alapi, (unknown), Tal Patalon, (unknown), (unknown), Gabriel Chodick, Mordechai Shohat	2
10	Mpox Patient Journey in Israel 2023 ·Microorganisms ·Tal Patalon, Galit Perez, Yaki Saciuk, (unknown), Sivan Gazit	1
11	Dynamics of Naturally Acquired Immunity Against Severe Acute Respiratory Syndrome Coronavirus 2 in Children and Adolescents 2023 ·The Journal of Pediatrics ·Tal Patalon, Yaki Saciuk, Galit Perez, Asaf Peretz, Amir Ben‐Tov, Sivan Gazit	6
12	Hybrid immunity against reinfection with SARS-CoV-2 following a previous SARS-CoV-2 infection and single dose of the BNT162b2 vaccine in children and adolescents: a target trial emulation 2023 ·The Lancet Microbe ·Sivan Gazit, Yaki Saciuk, Galit Perez, Asaf Peretz, Amir Ben‐Tov, Elizabeth A. Stuart, Tal Patalon	8
13	Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Naturally Acquired Immunity versus Vaccine-induced Immunity, Reinfections versus Breakthrough Infections: A Retrospective Cohort Study 2022 ·Clinical Infectious Diseases ·Sivan Gazit, (unknown), Galit Perez, Roni Lotan, Asaf Peretz, Amir Ben‐Tov, Esma Herzel, Hillel Alapi, Dani Cohen, Khitam Muhsen, Gabriel Chodick, Tal Patalon	90
14	Pregnancy outcomes after SARS-CoV-2 infection by trimester: A large, population-based cohort study 2022 ·PLoS ONE ·Noga Fallach, Yaakov Segal, (unknown), (unknown), Asaf Peretz, Gabriel Chodick, Sivan Gazit, Tal Patalon, Amir Ben‐Tov, Inbal Goldshtein	30
15	BNT162b2 mRNA Vaccine Effectiveness Given Confirmed Exposure: Analysis of Household Members of Coronavirus Disease 2019 Patients 2021 ·Clinical Infectious Diseases ·Sivan Gazit, Barak Mizrahi, Nir Kalkstein, Ami Neuberger, Asaf Peretz, (unknown), Amir Ben‐Tov, Tal Patalon	16
16	SARS-CoV-2 RT-qPCR Test Detection Rates Are Associated with Patient Age, Sex, and Time since Diagnosis 2021 ·Journal of Molecular Diagnostics ·Matan Levine-Tiefenbrun, Idan Yelin, (unknown), Jacob Kuint, Licita Schreiber, Esma Herzel, Rachel Katz, Amir Ben‐Tov, Sivan Gazit, Tal Patalon, Gabriel Chodick, Roy Kishony	8
17	Viral loads of Delta-variant SARS-CoV-2 breakthrough infections after vaccination and booster with BNT162b2 2021 ·Nature Medicine ·Matan Levine-Tiefenbrun, Idan Yelin, Hillel Alapi, Rachel Katz, Esma Herzel, Jacob Kuint, Gabriel Chodick, Sivan Gazit, Tal Patalon, Roy Kishony	139
18	Correlation of SARS-CoV-2-breakthrough infections to time-from-vaccine 2021 ·Nature Communications ·Barak Mizrahi, Roni Lotan, Nir Kalkstein, Asaf Peretz, Galit Perez, Amir Ben‐Tov, Gabriel Chodick, Sivan Gazit, Tal Patalon	172
19	Community-level evidence for SARS-CoV-2 vaccine protection of unvaccinated individuals 2021 ·Nature Medicine ·(unknown), Idan Yelin, (unknown), Rachel Katz, Esma Herzel, Amir Ben‐Tov, Jacob Kuint, Sivan Gazit, Gabriel Chodick, Tal Patalon, Roy Kishony	58
20	Initial report of decreased SARS-CoV-2 viral load after inoculation with the BNT162b2 vaccine breakdown → 2021 ·Nature Medicine ·Matan Levine-Tiefenbrun, Idan Yelin, Rachel Katz, Esma Herzel, (unknown), Licita Schreiber, Tamar Wolf, Varda Nadler, Amir Ben‐Tov, Jacob Kuint, Sivan Gazit, Tal Patalon, Gabriel Chodick, Roy Kishony	305

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact